NAYA Biosciences Inc. Com...

NASDAQ: IVF · Real-Time Price · USD
1.56
-0.19 (-10.86%)
At close: Aug 15, 2025, 3:59 PM
1.59
1.90%
After-hours: Aug 15, 2025, 07:58 PM EDT

NAYA Biosciences Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
840.41K 741.4K 471.59K 942.93K 475.13K 232.42K 1.06M 112.48K 2.19M 90.14K 285.7K 1.96M 3.84M 5.68M 4.71M 6.64M 8.42M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
710.86K 740.76K 2.94M 3.02M 3.04M 3.09M 1.08M 1.13M 1.17M 1.24M 1.28M 1.35M 1.49M 1.49M 237.48K 141.27K n/a
Other Long-Term Assets
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 200.58K 881.83K 280.16K
Receivables
173.61K 174.88K 257.05K 257.21K 176.89K 140.55K 116.78K 74.91K 99.72K 77.15K 71.31K 56.48K 58.72K 50.47K 50.66K 47.87K 527.65K
Inventory
216.46K 219.76K 241.54K 250.07K 266.45K 264.51K 254.22K 280.02K 270.92K 263.6K 280.13K 282K 294.63K 287.77K 290.39K 250.78K 268.35K
Other Current Assets
338.64K 182.29K 987.3K 945.85K 806.48K 622.29K 365.23K 374.71K 250.88K 190.2K n/a n/a n/a n/a n/a n/a n/a
Total Current Assets
1.57M 1.32M 1.96M 2.4M 1.72M 1.26M 1.79M 842.13K 2.81M 621.09K 942.29K 2.55M 4.42M 6.31M 5.33M 7.23M 9.58M
Property-Plant & Equipment
2.67M 2.75M 2.76M 3.06M 3.78M 4.19M 6.63M 4.66M 2.17M 1.85M 2.32M 2.4M 2.47M 2.54M 2.25M 1.55M 203.32K
Goodwill & Intangibles
26.79M 41.64M 9.36M 9.56M 9.77M 9.97M 9.97M n/a n/a n/a 132.68K 132.71K 132.55K 132.09K 132.15K 129.44K 123.49K
Total Long-Term Assets
30.17M 45.13M 15.06M 15.64M 16.59M 17.25M 17.68M 5.8M 3.34M 3.09M 3.74M 3.88M 4.1M 4.16M 2.82M 2.7M 606.97K
Total Assets
31.74M 46.45M 17.02M 18.03M 18.32M 18.51M 19.48M 6.64M 6.15M 3.71M 4.68M 6.42M 8.52M 10.47M 8.15M 9.93M 10.19M
Account Payables
4.79M 5.71M 2.66M 2.38M 2.8M 2.33M 1.85M 1.84M 1.85M 1.35M 689.56K 466.98K 462.21K 443.42K 515.58K 306.25K 512.04K
Deferred Revenue
725.33K 602.36K 562.4K 416.75K 513.42K 408.77K 229.92K 161.19K 46.75K 119.88K 98.66K 77.36K 5.79K 5.9K 714.29K 714.29K 714.29K
Short-Term Debt
5.38M 6.34M 1.72M 1.46M 1.68M 1.51M 1.7M 1.03M 1.1M 762.64K n/a n/a n/a n/a 340.54K 249.94K 343.08K
Other Current Liabilities
2.58M 2.53M 990.04K 996.84K 1.12M 1.07M 714.03K 1.2M 1.22M 946.26K 643.61K 508.8K 391.88K 581.69K 461.91K 349.66K 267.39K
Total Current Liabilities
18.72M 17.93M 8.66M 7.99M 8.96M 8M 4.88M 4.47M 4.45M 3.34M 1.66M 1.28M 1.08M 1.25M 2.14M 1.72M 1.86M
Long-Term Debt
1.09M 1.13M 1.13M 1.17M 1.21M 1.25M 1.09M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
6.48M 12.46M 5M 5M 5M 5M 7.5M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
9.69M 15.78M 8.39M 8.68M 9.35M 9.61M 14.22M 3.88M 1.61M 1.35M 1.73M 1.79M 1.85M 1.9M 3.65M 3.86M 2.73M
Total Liabilities
28.41M 33.7M 17.04M 16.67M 18.31M 17.61M 19.1M 8.34M 6.06M 4.69M 3.39M 3.07M 2.93M 3.16M 5.79M 5.57M 4.59M
Total Debt
8.84M 9.9M 5.34M 5.38M 6.38M 6.3M 8.81M 5.13M 2.95M 2.27M 1.96M 2.01M 2.07M 2.12M 1.78M 1.7M 418.93K
Common Stock
74.00 37.00 391.00 386.00 262.00 20.00 247.00 83.00 1.4K 61.00 1.22K 1.21K 1.21K 1.19K 1.05K 1.05K 1.04K
Retained Earnings
-84.87M -67.16M -63.54M -61.91M -59.41M -57.82M -55.82M -54.57M -52.33M -49.78M -47.02M -44.47M -41.67M -38.89M -38.75M -36.51M -34.69M
Comprehensive Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shareholders Equity
3.34M 12.75M -23.32K 1.36M 10.15K 892.6K 372.8K -1.71M 88.47K -977.61K 1.29M 3.36M 5.59M 7.31M 2.59M 4.36M 5.6M
Total Investments
710.86K 740.76K 2.94M 3.02M 3.04M 3.09M 1.08M 1.13M 1.17M 1.24M 1.28M 1.35M 1.49M 1.49M 237.48K 141.27K n/a